A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21

Journal of Immunology

Volumn 173, Issue 8, 2004, Pages 4791-4798

  Martin, Andrea P ^a   Coronel, Elizabeth C ^b   Sano, Gen Ichiro ^a   Chen, Shu Cheng ^b   Vassileva, Galya ^b   Canasto Chibuque, Claudia ^a   Sedgwick, Jonathon D ^b   Frenette, Paul S ^a   Lipp, Martin ^c   Furtado, Glaucia C ^a   Lira, Sergio A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADDRESSIN; BETA CHEMOKINE; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR7; L SELECTIN; LYMPHOTOXIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; THYROGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HASHIMOTO DISEASE; IMMUNOPATHOGENESIS; LYMPH NODE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THYROID GLAND; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VENULE;

EID: 6344238663     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.8.4791     Document Type: Article

References (66)

1. Juan, C. J. 2003. Endocrine autoimmunity. In Basic and Clinical Endocrinology. F. S. Greenspan, ed. Lange, New York.
2. Prummel, M. F., and W. M. Wiersinga. 2002. Autoimmune thyroid diseases. In Immmunologically Mediated Endocrine Diseases. R.G. Gill, J. T. Harmon, and N. K. Maclaren, eds. Lippincott Williams & Wilkins, Philadelphia, p. 373.
3. Davies, T. F. 2000. The pathogenesis of Graves' disease. In Wernere and Ingbar's The Thyroid. L. E. Baverman and R. D. Utiger, eds. Lippincott, Philadelphia, p. 518.
4. Barbesino, G., and T. F. Davies. 2002. The immunological mediation of Robert Graves' disease. In Immmunologically Mediated Endocrine Diseases. R. G. Gill, J. T. Harmon, and N. K. Maclaren, eds. Lippincott Williams & Wilkins, Philadelphia, p. 397.
5. Stassi, G., and R. De Maria. 2002. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2:195.
6. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565.
7. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121.
8. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61:246.
9. Romagnani, P., M. Rotondi, E. Lazzeri, L. Lasagni, M. Francalanci, A. Buonamano, S. Milani, P. Vitti, L. Chiovato, M. Tonacchera, et al. 2002. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am. J. Pathol. 161:195.
10. Bjorkdahl, O., K. A. Barber, S. J. Brett, M. O. Daly, C. Plumpton, N. A. Elshourbagy, J. P. Tite, and L. L. Thomsen. 2003. Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues. Immunology 110:170.
11. 2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759.
12. Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23.
13. Luther, S. A., H. L. Tang, P. L. Hyman, A. G. Farr, and J. G. Cyster. 2000. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. USA 97:12694.
14. Gunn, M. D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L. T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451.
15. Muller, G., U. E. Hopken, H. Stein, and M. Lipp. 2002. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J. Leukocyte Biol. 72:1.
16. Aust, G., M. Steinert, S. Kiessling, M. Kamprad, and C. Simchen. 2001. Reduced expression of stromal-derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells. J. Clin. Endocrinol. Metab. 86:3368.
17. Aust, G., M. Steinert, C. Boltze, S. Kiessling, and C. Simchen. 2001. GRO-α in normal and pathological thyroid tissues and its regulation in thyroid-derived cells. J. Endocrinol. 170:513.
18. + lymphocytes. J. Clin. Endocrinol Metab. 86:5008.
19. Kemp, E. H., R. A. Metcalfe, K. A. Smith, M. N. Woodroofe, P. F. Watson, and A. P. Weetman. 2003. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin. Endocrinol. 59:207.
20. Armengol, M. P., M. Juan, A. Lucas-Martin, M. T. Fernandez-Figueras, D. Jaraquemada, T. Gallart, and R. Pujol-Borrell. 2001. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am. J. Pathol. 159:861.
21. Simchen, C., I. Lehmann, D. Sittig, M. Steinert, and G. Aust. 2000. Expression and regulation of regulated on activation, normal T cells expressed and secreted in thyroid tissue of patients with Graves' disease and thyroid autonomy and in thyroid-derived cell populations. J. Clin. Endocrinol. Metab. 85:4758.
22. Ashhab, Y., O. Dominguez, M. Sospedra, C. Roura-Mir, A. Lucas-Martin, and R. Pujol-Borrell. 1999. A one-tube polymerase chain reaction protocol demonstrates CC chemokine overexpression in Graves' disease glands. J. Clin. Endocrinol. Metab. 84:2873.
23. Aust, G., D. Sittig, M. Steinert, P. Lamesch, and T. Lohmann. 2002. Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes. Clin. Exp. Immunol. 127:479.
24. Weetman, A. P., G. L. Bennett, and W. L. Wong. 1992. Thyroid follicular cells produce interleukin-8. J. Clin. Endocrinol. Metab. 75:328.
25. Kasai, K., N. Banba, S. Motohashi, Y. Hattori, K. Manaka, and S. I. Shimoda. 1996. Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes. FEBS Lett. 394:137.
26. + T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 170:6320.
27. Chen, S. C., G. Vassileva, D. Kinsley, S. Holzmann, D. Manfra, M. T. Wiekowski, N. Romani, and S. A. Lira. 2002. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168:1001.
28. Fan, L., C. R. Reilly, Y. Luo, M. E. Dorf, and D. Lo. 2000. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 164:3955.
29. Luther, S. A., A. Bidgol, D. C. Hargreaves, A. Schmidt, Y. Xu, J. Paniyadi, M. Matloubian, and J. G. Cyster. 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169:424.
30. Chen, S. C., M. W. Leach, Y. Chen, X. Y. Cai, L. Sullivan, M. Wiekowski, B. J. Dovey-Hartman, A. Zlotnik, and S. A. Lira. 2002. Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J. Immunol. 168:1009.
31. Vassileva, G., H. Soto, A. Zlotnik, H. Nakano, T. Kakiuchi, J. A. Hedrick, and S. A. Lira. 1999. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med. 190:1183.
32. Mann, J. R., and A. P. McMahon. 1993. Factors influencing production frequency of transgenic mice. Methods Enzymol. 225:771.
33. Hogan, B., F. Constantini, and L. Lacy. 1986. Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
34. Lira, S. A., R. A. Kinloch, S. Mortillo, and P. M. Wassarman. 1990. An upstream region of the mouse ZP3 gene directs expression of firefly luciferase specifically to growing oocytes in transgenic mice. Proc. Natl. Acad. Sci. USA 87:7215.
35. Korner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Kontgen, B. Fazekas de St. Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600.
36. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855.
37. Manfra, D. J., S. C. Chen, T. Y. Yang, L. Sullivan, M. T. Wiekowski, S. Abbondanzo, G. Vassileva, P. Zalamea, D. N. Cook, and S. A. Lira. 2001. Leukocytes expressing green fluorescent protein as novel reagents for adoptive cell transfer and bone marrow transplantation studies. Am. J. Pathol. 158:41.
38. Robinson, S. D., P. S. Frenette, H. Rayburn, M. Cummiskey, M. Ullman-Cullere, D. D. Wagner, and R. O. Hynes. 1999. Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment. Proc. Natl. Acad. Sci. USA 96:11452.
39. Yang, T. Y., S. C. Chen, M. W. Leach, D. Manfra, B. Homey, M. Wiekowski, L. Sullivan, C. H. Jenh, S. K. Narula, S. W. Chensue, and S. A. Lira. 2000. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191:445.
40. Chiappetta, G., N. Fabien, A. Picone, D. Califano, C. Monaco, V. de Franciscis, G. Vecchio, and G. Santelli. 1996. Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization. Oncol. Res. 8:85.
41. Rochefort, P., B. Caillou, F. M. Michiels, C. Ledent, M. Talbot, M. Schlumberger, F. Lavelle, R. Monier, and J. Feunteun. 1996. Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene 12:111.
42. Santoro, M., G. Chiappetta, A. Cerrato, D. Salvatore, L. Zhang, G. Manzo, A. Picone, G. Portella, G. Santelli, G. Vecchio, and A. Fusco. 1996. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12:1821.
43. Wallace, H., A. R. Clarke, D. J. Harrison, M. L. Hooper, and J. O. Bishop. 1996. Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis. Oncogene 13:55.
44. Caturegli, P., M. Hejazi, K. Suzuki, O. Dohan, N. Carrasco, L. D. Kohn, and N. R. Rose. 2000. Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid. Proc. Natl. Acad. Sci. USA 97:1719.
45. Caturegli, P., N. R. Rose, M. Kimura, H. Kimura, and S. C. Tzou. 2003. Studies on murine thyroiditis: new insights from organ flow cytometry. Thyroid 13:419.
46. Muller, G., U. E. Hopken, and M. Lipp. 2003. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 195:117.
47. Gosling, J., D. J. Dairaghi, Y. Wang, M. Hanley, D. Talbot, Z. Miao, and T. J. Schall. 2000. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 164:2851.
48. Townson, J. R., and R. J. Nibbs. 2002. Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3β/mCCL19: comparison to human CCX-CKR. Eur. J. Immunol. 32:1230.
49. Mebius, R. E. 2003. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3:292.
50. Hjelmstrom, P., J. Fjell, T. Nakagawa, R. Sacca, C. A. Cuff, and N. H. Ruddle. 2000. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156:1133.
51. Nagira, M., T. Imai, R. Yoshida, S. Takagi, M. Iwasaki, M. Baba, Y. Tabira, J. Akagi, H. Nomiyama, and O. Yoshie. 1998. A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells. Eur. J. Immunol. 28:1516.
52. Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95:258.
53. Ebisuno, Y., T. Tanaka, N. Kanemitsu, H. Kanda, K. Yamaguchi, T. Kaisho, S. Akira, and M. Miyasaka. 2003. Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J. Immunol. 171:1642.
54. Campbell, J. J., K. E. Murphy, E. J. Kunkel, C. E. Brightling, D. Soler, Z. Shen, J. Boisvert, H. B. Greenberg, M. A. Vierra, S. B. Goodman, et al. 2001. CCR7 expression and memory T cell diversity in humans. J. Immunol. 166:877.
55. Stein, J. V., S. F. Soriano, C. M'Rini, C. Nombela-Arrieta, G. G. de Buitrago, J. M. Rodriguez-Frade, M. Mellado, J. P. Girard, and A. C. Martinez. 2003. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood 101:38.
56. 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413.
57. Stein, J. V., A. Rot, Y. Luo, M. Narasimhaswamy, H. Nakano, M. D. Gunn, A. Matsuzawa, E. J. Quackenbush, M. E. Dorf, and U. H. von Andrian. 2000. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191:61.
58. Soto, H., W. Wang, R. W. Strieter, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, J. Hedrick, and A. Zlotnik. 1998. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA 95:8205.
59. Matsumoto, M., Y. X. Fu, H. Molina, and D. D. Chaplin. 1997. Lymphotoxin-α-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137.
60. Ruddle, N. H. 1999. Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. Immunol. Res. 19:119.
61. Tumanov, A. V., D. V. Kuprash, and S. A. Nedospasov. 2003. The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev. 14:275.
62. Harmsen, A., K. Kusser, L. Hartson, M. Tighe, M. J. Sunshine, J. D. Sedgwick, Y. Choi, D. R. Littman, and T. D. Randall. 2002. Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-α (LT α) and retinoic acid receptor-related orphan receptor-γ, but the organization of NALT is LT α dependent. J. Immunol. 168:986.
63. + cells. Immunity 17:31.
64. Luther, S. A., T. Lopez, W. Bai, D. Hanahan, and J. G. Cyster. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12:471.
65. Eberl, G., and D. R. Littman. 2003. The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195:81.
66. Eberl, G., S. Marmon, M. J. Sunshine, P. D. Rennert, Y. Choi, and D. R. Littman. 2004. An essential function for the nuclear receptor RORγ(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5:64.